Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 08:45 (573 d 07:46 ago) – Posting: # 20125
Views: 2,412

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,179 posts in 4,414 threads, 1,477 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Thursday 15:31 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5